Search

Search results

Woman in lab coat plating

Medical research

Retina UK has invested more than £16million into cutting-edge research since the charity was founded in 1976.

A man wearing a red checked shirt standing at a lectern in front of a number of seated people

The Gene Team

Funding from Retina UK has allowed to team to explore the viability of gene therapy as a treatment for RP and related conditions, and build a pipeline of clinical trials.

Genetic testing: an essential topic for discussion with the IRD community

As Luxturna reaches the clinic and other gene-specific therapies for inherited retinal disease get closer to the end of the development pipeline, it is becoming ever more important that affected families can access a genetic diagnosis, potentially opening up choices around treatment and clinical trial participation.